Perjeta, also known as pertuzumab, is a crucial advancement in managing HER2-positive certain types of cancer. The medication works by targeting a distinct pathway on helps cancer cells grow . Unlike some other HER2-targeted therapies, pertuzumab doesn’t directly block the HER2 receptor itself, b… Read More